Omzo vs Wellorithm: Pricing, Coverage, and Compounded GLP-1 Care

Quick verdict: Omzo vs Wellorithm

Omzo focuses on clinician-guided plans with compounded semaglutide starting at $179 and may provide prescriptions for branded medications; Wellorithm starts at $147 and advertises licensed clinicians in all 50 states with fully virtual consultations. Early verdict: choose Omzo if you want clinician options that can include prescriptions for branded products and compounded programs; choose Wellorithm if you need nationwide clinician coverage and lower published entry pricing.

Explore Omzo clinician-guided plans

How they differ: price transparency and starting costs

Both platforms offer compounded semaglutide and tirzepatide but they present pricing differently. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. Wellorithm advertises starting offers as low as $147 and multiple starting price points across formulations, but it also does not publish full pricing for every plan and may deliver a personalized quote after the intake quiz.

Start Wellorithm eligibility quiz

Coverage and clinician availability

The providers differ sharply on clinician reach. Wellorithm states it has licensed clinicians in all 50 states, positioning itself for patients in states where options can be limited. Omzo connects patients with licensed U.S. providers via third party networks but does not claim 50-state clinician coverage in the provided evidence.

See Omzo state availability

Medication type and prescribing model

Both offer compounded semaglutide and tirzepatide. Omzo describes a compounded Medication Program prepared by a state licensed sterile compounding pharmacy and notes these compounded drugs are not FDA approved. Omzo also states providers may write prescriptions for branded FDA approved medications, but Omzo does not sell or ship branded meds and patients are responsible for filling and costs. Wellorithm offers compounded semaglutide and tirzepatide and also notes compounded medications are not FDA approved.

Service model and delivery

Wellorithm emphasizes a fully virtual workflow: a 2 minute quiz, virtual consultation, and medication shipped to your home with fast, free shipping in some offers. Omzo highlights fast, discreet delivery and that clinical services are provided by third party networks of U.S. licensed clinicians who determine eligibility and prescribe based on medical judgment.

Regulatory note common to both

Both providers state that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or quality. Each platform ties treatment availability to clinician judgment and eligibility determined through assessment.

Side by side: key differences table

Practical differences that matter

Omzo emphasizes clinician-guided plans and explicitly explains options for compounded programs and prescriptions for branded medications, noting Omzo does not sell or ship branded drugs. Wellorithm stresses broad access through a 50-state clinician network and a fully virtual process beginning with a short quiz. Wellorithm also promotes lower advertised entry pricing and free shipping in captured messaging, while Omzo lists specific starting prices for key medications.

Check Wellorithm availability and pricing

Choose Omzo if…

Choose Omzo if you want clinician-guided plans that include a compounded medication program with the option that a provider may write a prescription for branded FDA approved medications and you value upfront starting prices listed for semaglutide and tirzepatide.

Choose Wellorithm if…

Choose Wellorithm if you need licensed clinician access across all 50 states, prefer a fully virtual intake and shipping model, and want the lowest advertised starting price that appears in the captured evidence.

Compare Omzo plans now